Home » News » Awards & Advancement » Biothera names chief medical officer

Biothera names chief medical officer

Monday, November 21, 2011

Biothera has named Patricia Molloy, M.D., chief medical officer. In this role, Molloy is responsible for the clinical development of Imprime PGG, the company’s immunotherapeutic oncology drug that is currently in multiple clinical trials for colorectal and lung cancer and chronic lymphocytic leukemia.

Molloy has more than 20 years of research experience with extensive late stage clinical development expertise in oncology, neurology and pediatrics. She was most recently vice president, global medical affairs and strategic consulting, for Premier Research Group.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!